Drug Overview
baclofen amitriptyline ketamine gel (commonly referred to as BAK Gel) is a topical “Targeted Therapy” used to manage localized nerve pain. Unlike oral medications that circulate through the entire body, this gel is applied directly to the skin to deliver high concentrations of medicine to painful areas while minimizing systemic side effects.
- Generic Name: Baclofen, Amitriptyline Hydrochloride, and Ketamine Hydrochloride Topical Gel.
- US Brand Names: None. This is a compounded medication, meaning it is custom-prepared by specialized pharmacies rather than sold as a pre-packaged brand.
- Drug Class: Topical Analgesic; Multimodal Neuropathic Pain Agent.
- Route of Administration: Topical (applied to the skin).
- FDA Approval Status: The individual ingredients are FDA-approved for other uses, but this specific combination gel is not FDA-approved. It is used “off-label” and is frequently studied in clinical trials.
Explore the pain management benefits of baclofen amitriptyline ketamine gel. Our top-rated hospital offers expert supportive care for every patient.
What Is It and How Does It Work? (Mechanism of Action)

BAK gel works by combining three different types of medicine that target pain at the molecular level in the peripheral nerves.
1. Baclofen (The Muscle & Nerve Relaxer)
Baclofen is a GABA_B receptor agonist. At the molecular level, it binds to these receptors on the ends of nerve cells. This action causes hyperpolarization (making the cell less likely to “fire”) and inhibits the release of excitatory neurotransmitters like glutamate. This effectively “quiets” overactive pain signals.
2. Amitriptyline (The Signal Blocker)
While often used as an antidepressant, in this gel, amitriptyline acts as a sodium channel blocker. It prevents sodium ions from entering nerve cells, which is necessary for a pain signal to travel along a nerve. By blocking these channels, it stops the electrical “message” of pain from reaching the brain. It also interacts with adenosine receptors to further decrease pain sensitivity.
3. Ketamine (The Central Sensitization Blocker)
Ketamine is an NMDA receptor antagonist. When nerves are damaged, they often become oversensitive due to constant stimulation of NMDA receptors by glutamate. Ketamine blocks these receptors, preventing the “wind-up” effect where pain feels more intense over time.
FDA Approved Clinical Indications
Although not FDA-approved as a single product, BAK gel is widely recognized in professional guidelines (such as those from ASCO) for specific uses:
- Oncological Uses:
- Chemotherapy-Induced Peripheral Neuropathy (CIPN): Treating the numbness, tingling, and “pins and needles” sensations in the hands and feet caused by drugs like oxaliplatin, paclitaxel, or cisplatin.
- Radiation-induced skin pain (dermatitis).
- Non-oncological Uses:
- Post-herpetic neuralgia (pain following shingles).
- Diabetic peripheral neuropathy.
- Localized chronic nerve pain or fibromyalgia-related pain points.
Dosage and Administration Protocols
BAK gel must be applied consistently to maintain a steady level of the medication in the skin tissue.
| Parameter | Standard Protocol (e.g., NCCTG N06CA Study) |
| Concentration | Baclofen 10mg / Amitriptyline 40mg / Ketamine 20mg (per 4g of gel) |
| Standard Dose | One pump or 4g of gel per application |
| Frequency | Applied twice daily (morning and evening) |
| Application Sites | Clean, dry skin of the hands and/or feet |
| Duration of Use | Typically assessed after 4 weeks of continuous use |
Dose Adjustments:
- Renal/Hepatic Insufficiency: Because systemic absorption is extremely low, dose adjustments are usually not required for patients with kidney or liver issues. However, patients with a serum creatinine >1.5 times the normal limit should be monitored closely as a precaution.
Clinical Efficacy and Research Results
Current clinical data (2020–2025) and landmark studies provide evidence for the use of BAK gel in supportive cancer care.
- Symptom Reduction: In the foundational Phase III trial (NCCTG N06CA), patients using BAK gel reported a significant decrease in sensory neuropathy scores compared to those using a placebo.
- Numerical Data: Clinical reviews show that up to 30–40% of patients experience a meaningful reduction in “tingling and burning” scores within the first month of treatment.
- Quality of Life: Unlike oral treatments like gabapentin, which can cause significant grogginess, BAK gel allows patients to manage pain without affecting their daily mental clarity, leading to higher patient satisfaction scores.
- Survival Rates: This drug does not affect cancer survival rates directly; however, it helps patients stay on their life-saving chemotherapy longer by reducing the side effects that often lead to dose reductions.
Safety Profile and Side Effects
BAK gel is generally considered safer than oral nerve medications because very little of the drug enters the bloodstream.
Black Box Warning: While the gel has no specific box warning, the systemic component Amitriptyline carries a warning for increased suicidal thoughts in young adults. The Ketamine component also carries potential for misuse, though the topical risk is considered negligible.
Common Side Effects (>10%)
- Skin Irritation: Redness, dryness, or itching at the site of application.
- Mild Numbness: A temporary “deadened” feeling in the skin where applied.
Serious Adverse Events (Rare)
- Drowsiness/Dizziness: Can occur if too much gel is applied or if the skin barrier is damaged, allowing for higher absorption.
- Allergic Contact Dermatitis: A severe rash or hives.
- Confusion: Extremely rare, typically only in elderly patients with very thin skin.
Management Strategies
- If skin irritation occurs, stop use and apply a mild moisturizer.
- Wash hands thoroughly after application (unless treating the hands) to avoid accidentally getting the gel in your eyes or mouth.
Research Areas
BAK gel is currently being explored as part of Regenerative Medicine research into “nerve-sparing” protocols. Scientists are investigating whether applying BAK gel during chemotherapy can act as a shield to prevent permanent nerve damage. Additionally, research is looking into combining BAK gel with stem cell-derived growth factors to promote the actual repair of damaged nerves rather than just masking the pain.
Patient Management and Practical Recommendations
Pre-treatment Tests
- Pain Assessment: Complete a 0–10 scale rating of numbness and tingling.
- Kidney Function: A baseline creatinine test to ensure normal drug clearance.
Precautions During Treatment
- Do Not Apply to Broken Skin: Avoid cuts, scrapes, or open sores.
- Avoid Heat: Do not use heating pads on the area after applying, as heat can increase drug absorption into the blood.
“Do’s and Don’ts”
- DO apply to clean, dry skin.
- DO wait at least 15 minutes before putting on socks or gloves.
- DON’T use more than the prescribed amount.
- DON’T stop treatment abruptly; the full effect often takes 2–4 weeks to appear.
Legal Disclaimer
The information in this guide is for educational purposes only and does not constitute medical advice. BAK gel is a compounded medication and its safety and efficacy as a combination product have not been evaluated by the FDA. Always consult with your oncologist or a pain management specialist before starting new treatments. Individual results may vary.